{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:47:22Z","timestamp":1788583642390,"version":"build-2803163510"},"reference-count":201,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"FWF Austrian Science Fund","doi-asserted-by":"publisher","award":["P 33225"],"award-info":[{"award-number":["P 33225"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Voltage-gated calcium channels (VGCCs) are widely expressed in the brain, heart and vessels, smooth and skeletal muscle, as well as in endocrine cells. VGCCs mediate gene transcription, synaptic and neuronal structural plasticity, muscle contraction, the release of hormones and neurotransmitters, and membrane excitability. Therefore, it is not surprising that VGCC dysfunction results in severe pathologies, such as cardiovascular conditions, neurological and psychiatric disorders, altered glycemic levels, and abnormal smooth muscle tone. The latest research findings and clinical evidence increasingly show the critical role played by VGCCs in autism spectrum disorders, Parkinson\u2019s disease, drug addiction, pain, and epilepsy. These findings outline the importance of developing selective calcium channel inhibitors and modulators to treat such prevailing conditions of the central nervous system. Several small molecules inhibiting calcium channels are currently used in clinical practice to successfully treat pain and cardiovascular conditions. However, the limited palette of molecules available and the emerging extent of VGCC pathophysiology require the development of additional drugs targeting these channels. Here, we provide an overview of the role of calcium channels in neurological disorders and discuss possible strategies to generate novel therapeutics.<\/jats:p>","DOI":"10.3390\/molecules27041312","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T22:44:47Z","timestamp":1644965087000},"page":"1312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-6028","authenticated-orcid":false,"given":"Stefano","family":"Lanzetti","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Peter-Mayr Strasse 1, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-6516","authenticated-orcid":false,"given":"Valentina","family":"Di Biase","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Peter-Mayr Strasse 1, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3345\/kjp.2014.57.1.1","article-title":"Channelopathies","volume":"57","author":"Kim","year":"2014","journal-title":"Korean J. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","article-title":"Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders","volume":"134","author":"Heyes","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00424-020-02368-3","article-title":"Skeletal muscle CaV1.1 channelopathies","volume":"472","author":"Flucher","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00424-020-02420-2","article-title":"Neuronal alpha2delta proteins and brain disorders","volume":"472","author":"Ablinger","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00424-020-02430-0","article-title":"Cav1.2 channelopathies causing autism: New hallmarks on Timothy syndrome","volume":"472","author":"Marcantoni","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"634760","DOI":"10.3389\/fnsyn.2021.634760","article-title":"Voltage-Gated Ca(2+)-Channel alpha1-Subunit de novo Missense Mutations: Gain or Loss of Function\u2014Implications for Potential Therapies","volume":"13","author":"Striessnig","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","article-title":"From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms","volume":"14","author":"Kabir","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00424-020-02429-7","article-title":"Neuronal Cav3 channelopathies: Recent progress and perspectives","volume":"472","author":"Lory","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2019-106163","article-title":"Genetic T-type calcium channelopathies","volume":"57","author":"Weiss","year":"2020","journal-title":"J. Med. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2398212818794805","DOI":"10.1177\/2398212818794805","article-title":"Voltage-gated calcium channels: Their discovery, function and importance as drug targets","volume":"2","author":"Dolphin","year":"2018","journal-title":"Brain Neurosci. Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0166-2236(88)90194-4","article-title":"Multiple types of neuronal calcium channels and their selective modulation","volume":"11","author":"Tsien","year":"1988","journal-title":"Trends Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/316440a0","article-title":"Three types of neuronal calcium channel with different calcium agonist sensitivity","volume":"316","author":"Nowycky","year":"1985","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/310501a0","article-title":"A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones","volume":"310","author":"Carbone","year":"1984","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1523\/JNEUROSCI.14-08-05011.1994","article-title":"Omega-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons","volume":"14","author":"Boland","year":"1994","journal-title":"J. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0896-6273(89)90191-8","article-title":"Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons","volume":"2","author":"Plummer","year":"1989","journal-title":"Neuron"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/355827a0","article-title":"P-type calcium channels blocked by the spider toxin omega-Aga-IVA","volume":"355","author":"Mintz","year":"1992","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1073\/pnas.86.5.1689","article-title":"Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison","volume":"86","author":"Llinas","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1523\/JNEUROSCI.15-04-02995.1995","article-title":"Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons","volume":"15","author":"Randall","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1523\/JNEUROSCI.0339-14.2014","article-title":"Inhibition of A-type potassium current by the peptide toxin SNX-482","volume":"34","author":"Kimm","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1073\/pnas.0502506102","article-title":"Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations","volume":"102","author":"Splawski","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1074\/jbc.M109.076448","article-title":"Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation","volume":"285","author":"Yarotskyy","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0707414","article-title":"Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels","volume":"152","author":"Yarotskyy","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/nm.2576","article-title":"Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome","volume":"17","author":"Pasca","year":"2011","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.209","article-title":"Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder","volume":"40","author":"Ferreira","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.mp.4002151","article-title":"Whole-genome association study of bipolar disorder","volume":"13","author":"Sklar","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajmg.b.30962","article-title":"Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/mp.2009.49","article-title":"The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia","volume":"15","author":"Green","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/mp.2009.124","article-title":"Genome-wide association study of recurrent early-onset major depressive disorder","volume":"16","author":"Shi","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/mp.2009.69","article-title":"CACNA1C (rs1006737) is associated with schizophrenia","volume":"15","author":"Nyegaard","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cross-Disorder Group of the Psychiatric Genomics Consortium (2013). Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet, 381, 1371\u20131379.","DOI":"10.1016\/S0140-6736(12)62129-1"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421\u2013427.","DOI":"10.1038\/nature13595"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/srep00634","article-title":"Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals","volume":"2","author":"Hori","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2015.28","article-title":"Targeting the schizophrenia genome: A fast track strategy from GWAS to clinic","volume":"20","author":"Lencz","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41431-017-0059-1","article-title":"Genetic variant in CACNA1C is associated with PTSD in traumatized police officers","volume":"26","author":"Krzyzewska","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/s41380-020-0730-8","article-title":"Dopamine D1R-neuron cacna1c deficiency: A new model of extinction therapy-resistant post-traumatic stress","volume":"26","author":"Bavley","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nn.2694","article-title":"Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness","volume":"14","author":"Baig","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0092-8674(00)00013-1","article-title":"Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels","volume":"102","author":"Platzer","year":"2000","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-020-02418-w","article-title":"De novo CACNA1D Ca(2+) channelopathies: Clinical phenotypes and molecular mechanism","volume":"472","author":"Ortner","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.1424958112","article-title":"Rare variants in neuronal excitability genes influence risk for bipolar disorder","volume":"112","author":"Ament","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","first-page":"145","article-title":"A Rare Variant in CACNA1D Segregates with 7 Bipolar I Disorder Cases in a Large Pedigree","volume":"2","author":"Ross","year":"2016","journal-title":"Mol. Neuropsychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/s41598-021-82210-7","article-title":"Function of cone and cone-related pathways in CaV1.4 IT mice","volume":"11","author":"Zanetti","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4614-0631-0_48","article-title":"Congenital stationary night blindness: Mutation update and clinical variability","volume":"723","author":"Lodha","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuron.2013.10.056","article-title":"Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca(2)(+) channel due to a familial hemiplegic migraine mutation","volume":"81","author":"Inagaki","year":"2014","journal-title":"Neuron"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17678","DOI":"10.1074\/jbc.M501110200","article-title":"Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma","volume":"280","author":"Tottene","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: Emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.1100869108","article-title":"T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome","volume":"108","author":"Marger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00221-002-1217-3","article-title":"Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury","volume":"147","author":"Cizkova","year":"2002","journal-title":"Exp. Brain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J. Neurophysiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1744-8069-9-67","article-title":"Spinal morphine but not ziconotide or gabapentin analgesia is affected by alternative splicing of voltage-gated calcium channel CaV2.2 pre-mRNA","volume":"9","author":"Jiang","year":"2013","journal-title":"Mol. Pain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1124\/pr.58.4.11","article-title":"Direct G protein modulation of Cav2 calcium channels","volume":"58","author":"Tedford","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0896-6273(03)00801-8","article-title":"Cell-specific alternative splicing increases calcium channel current density in the pain pathway","volume":"41","author":"Bell","year":"2004","journal-title":"Neuron"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1523\/JNEUROSCI.0307-07.2007","article-title":"Differential role of N-type calcium channel splice isoforms in pain","volume":"27","author":"Altier","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_59","first-page":"E12043","article-title":"Ablation of alpha2delta-1 inhibits cell-surface trafficking of endogenous N-type calcium channels in the pain pathway in vivo","volume":"115","author":"Ramgoolam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats","volume":"21","author":"Luo","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin","volume":"29","author":"Bauer","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1517\/14656566.2014.922544","article-title":"Pharmacotherapy of focal epilepsy","volume":"15","author":"Iyer","year":"2014","journal-title":"Expert Opin. Pharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(03)01625-X","article-title":"Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents","volume":"467","author":"Hainsworth","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/epi.12250","article-title":"Cav 2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo","volume":"54","author":"Dibue","year":"2013","journal-title":"Epilepsia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.0013-9580.2005.35304.x","article-title":"Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels","volume":"46","author":"Kuzmiski","year":"2005","journal-title":"Epilepsia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1523\/JNEUROSCI.2081-08.2009","article-title":"Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy","volume":"29","author":"Ernst","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(99)00307-1","article-title":"Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat","volume":"75","author":"Talley","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1523\/JNEUROSCI.5295-08.2009","article-title":"A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy","volume":"29","author":"Powell","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00424-009-0772-x","article-title":"Role of voltage-gated calcium channels in epilepsy","volume":"460","author":"Zamponi","year":"2010","journal-title":"Pflugers Arch."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.21169","article-title":"Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants","volume":"62","author":"Heron","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1523\/JNEUROSCI.1817-06.2007","article-title":"The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: A paradigm for childhood absence epilepsy mutations","volume":"27","author":"Vitko","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9681","DOI":"10.1074\/jbc.C400006200","article-title":"Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy","volume":"279","author":"Khosravani","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22085","DOI":"10.1074\/jbc.M603316200","article-title":"CACNA1H mutations in Autism. spectrum disorders","volume":"281","author":"Splawski","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/brain\/awab101","article-title":"CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders","volume":"144","author":"Schneeberger","year":"2021","journal-title":"Brain"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: Physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrn3311","article-title":"Calcium channel auxiliary alpha2delta and beta subunits: Trafficking and one step beyond","volume":"13","author":"Dolphin","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage-gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","article-title":"Presynaptic calcium channels: Specialized control of synaptic neurotransmitter release","volume":"21","author":"Dolphin","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1152\/physrev.00029.2007","article-title":"Supramolecular assemblies and localized regulation of voltage-gated ion channels","volume":"89","author":"Dai","year":"2009","journal-title":"Physiol Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yjmcc.2012.12.006","article-title":"CaV1.2 signaling complexes in the heart","volume":"58","author":"Harvey","year":"2013","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e99771","DOI":"10.15252\/embj.201899771","article-title":"Postsynaptic localization and regulation of AMPA receptors and Cav1.2 by beta2 adrenergic receptor\/PKA and Ca(2+)\/CaMKII signaling","volume":"37","author":"Patriarchi","year":"2018","journal-title":"EMBO J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2017.12.004","article-title":"Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders","volume":"185","author":"Wild","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1471-4159.2008.05286.x","article-title":"Ca(v)1 L-type Ca2+ channel signaling complexes in neurons","volume":"105","author":"Lee","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","article-title":"Calcium Channels, Synaptic Plasticity, and Neuropsychiatric Disease","volume":"98","author":"Nanou","year":"2018","journal-title":"Neuron"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.123.4.949","article-title":"Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits","volume":"123","author":"Hell","year":"1993","journal-title":"J. Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.celrep.2019.03.005","article-title":"Synapse-to-Nucleus Communication through NFAT Is Mediated by L-type Ca(2+) Channel Ca(2+) Spike Propagation to the Soma","volume":"26","author":"Wild","year":"2019","journal-title":"Cell Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuron.2007.06.032","article-title":"AKAP79\/150 anchoring of calcineurin controls neuronal L-type Ca2+ channel activity and nuclear signaling","volume":"55","author":"Oliveria","year":"2007","journal-title":"Neuron"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2012.03.041","article-title":"Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression","volume":"149","author":"Wheeler","year":"2012","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.15252\/embj.201593409","article-title":"Phosphorylation of Cav1.2 on S1928 uncouples the L-type Ca2+ channel from the beta2 adrenergic receptor","volume":"35","author":"Patriarchi","year":"2016","journal-title":"EMBO J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/19336950.2020.1807851","article-title":"Loss of Cav1.2 channels impairs hippocampal theta burst stimulation-induced long-term potentiation","volume":"14","author":"Sridharan","year":"2020","journal-title":"Channels"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1132915","article-title":"BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling","volume":"314","author":"Berkefeld","year":"2006","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"34528","DOI":"10.1038\/srep34528","article-title":"Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology","volume":"6","author":"Stanika","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1523\/JNEUROSCI.3327-04.2005","article-title":"G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain","volume":"25","author":"Olson","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1152\/jn.00422.2013","article-title":"Regulation of dendritic calcium release in striatal spiny projection neurons","volume":"110","author":"Plotkin","year":"2013","journal-title":"J. Neurophysiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1152\/physrev.00030.2017","article-title":"Voltage-Gated Calcium Channels: Key Players in Sensory Coding in the Retina and the Inner Ear","volume":"98","author":"Pangrsic","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11577","DOI":"10.1523\/JNEUROSCI.3411-05.2005","article-title":"Few CaV1.3 channels regulate the exocytosis of a synaptic vesicle at the hair cell ribbon synapse","volume":"25","author":"Brandt","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-1-4419-1399-9_63","article-title":"Congenital stationary night blindness in mice\u2014A tale of two Cacna1f mutants","volume":"664","author":"Lodha","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2012.06.012","article-title":"The presynaptic active zone","volume":"75","author":"Sudhof","year":"2012","journal-title":"Neuron"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.7832825","article-title":"Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission","volume":"264","author":"Wheeler","year":"1994","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fncel.2013.00244","article-title":"Molecular mechanisms driving homeostatic plasticity of neurotransmitter release","volume":"7","author":"Lazarevic","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuron.2004.07.014","article-title":"Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy","volume":"43","author":"Cao","year":"2004","journal-title":"Neuron"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/44586","article-title":"P\/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A","volume":"401","author":"Sutton","year":"1999","journal-title":"Nature"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fncel.2015.00008","article-title":"Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans","volume":"9","author":"Vecchia","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","year":"2003","journal-title":"Physiol. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1073\/pnas.0601261103","article-title":"Specific T-type calcium channel isoforms are associated with distinct burst phenotypes in deep cerebellar nuclear neurons","volume":"103","author":"Molineux","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0006-3495(01)76100-0","article-title":"Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties","volume":"80","author":"Chemin","year":"2001","journal-title":"Biophys. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archgenpsychiatry.2010.96","article-title":"Genetic variation in CACNA1C affects brain circuitries related to mental illness","volume":"67","author":"Bigos","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1017\/S0033291710002217","article-title":"Effects of a CACNA1C genotype on attention networks in healthy individuals","volume":"41","author":"Thimm","year":"2011","journal-title":"Psychol Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.neuroimage.2009.09.028","article-title":"Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals","volume":"49","author":"Krug","year":"2010","journal-title":"Neuroimage"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JCP.0000000000001274","article-title":"Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia: A Pilot Study","volume":"40","author":"Vahdani","year":"2020","journal-title":"J. Clin. PsychoPharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41380-019-0583-1","article-title":"Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain","volume":"25","author":"Clark","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2017.06.029","article-title":"Relevance of tissue specific subunit expression in channelopathies","volume":"132","author":"Seitter","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bdi.12143","article-title":"Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association","volume":"16","author":"Ostacher","year":"2014","journal-title":"Bipolar Disord"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1113\/jphysiol.2008.161737","article-title":"The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: Multiple altered gating mechanisms and pharmacological restoration of inactivation","volume":"587","author":"Yarotskyy","year":"2009","journal-title":"J. Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.aad3647","article-title":"Sequential ionic and conformational signaling by calcium channels drives neuronal gene expression","volume":"351","author":"Li","year":"2016","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13229-019-0310-4","article-title":"Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder","volume":"11","author":"Hofer","year":"2020","journal-title":"Mol. Autism."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2040-2392-3-18","article-title":"Support for calcium channel gene defects in Autism. spectrum disorders","volume":"3","author":"Lu","year":"2012","journal-title":"Mol. Autism."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/mp.2009.41","article-title":"High-density SNP association study of the 17q21 chromosomal region linked to Autism. identifies CACNA1G as a novel candidate gene","volume":"15","author":"Strom","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/nedt.2007.3.2.237","article-title":"The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic","volume":"3","author":"Strawn","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_120","first-page":"115","article-title":"Neural circuits in anxiety and stress disorders: A focused review","volume":"11","author":"Duval","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1749-6632.2003.tb07078.x","article-title":"L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning","volume":"985","author":"McKernan","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_122","first-page":"127","article-title":"Experimental reseArch. on the effect of calcium channel blockers nifedipine and verapamil on the anxiety in mice","volume":"34","author":"Fulga","year":"1997","journal-title":"Rom. J. Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/S1461145709990368","article-title":"CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype","volume":"13","author":"Busquet","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/emboj\/20.10.2349","article-title":"Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel","volume":"20","author":"Saegusa","year":"2001","journal-title":"EMBO J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson\u2019s disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00002512-200825080-00004","article-title":"Pathophysiology and treatment of psychosis in Parkinson\u2019s disease: A review","volume":"25","author":"Zahodne","year":"2008","journal-title":"Drugs Aging"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: A review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/1871527313666140806142955","article-title":"The paths to neurodegeneration in genetic Parkinson\u2019s disease","volume":"13","year":"2014","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","article-title":"Use of antihypertensives and the risk of Parkinson disease","volume":"70","author":"Becker","year":"2008","journal-title":"Neurology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/aje\/kwr362","article-title":"Use of calcium channel blockers and Parkinson\u2019sdisease","volume":"175","author":"Pasternak","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","article-title":"L-type calcium channel blockers and Parkinson disease in Denmark","volume":"67","author":"Ritz","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pharmtox-010818-021214","article-title":"The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson\u2019s Disease","volume":"59","author":"Liss","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"15414","DOI":"10.1523\/JNEUROSCI.4742-09.2009","article-title":"Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons","volume":"29","author":"Putzier","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.22801","article-title":"A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson\u2019s disease","volume":"25","author":"Chan","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awt134","article-title":"Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins","volume":"136","author":"Hurley","year":"2013","journal-title":"Brain"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1523\/JNEUROSCI.21-16-05944.2001","article-title":"Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines","volume":"21","author":"Xu","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.118.112441","article-title":"Molecular Determinants of the Differential Modulation of Cav1.2 and Cav1.3 by Nifedipine and FPL 64176","volume":"94","author":"Wang","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1152\/jn.00486.2004","article-title":"L-type calcium channels: The low down","volume":"92","author":"Lipscombe","year":"2004","journal-title":"J. Neurophysiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/mds.25639","article-title":"Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson\u2019s disease (STEADY-PD)","volume":"28","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group STEADY-PD III Investigators (2020). Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial. Ann. Intern. Med., 172, 591\u2013598.","DOI":"10.7326\/M19-2534"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/acn3.51300","article-title":"Isradipine plasma pharmacokinetics and exposure-response in early Parkinson\u2019s disease","volume":"8","author":"Venuto","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1172\/JCI46482","article-title":"Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease","volume":"121","author":"Tai","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","article-title":"T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease","volume":"11","author":"Tabata","year":"2018","journal-title":"Stem Cell Reports"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/acschemneuro.9b00031","article-title":"T-Type Channel Druggability at a Crossroads","volume":"10","author":"Weiss","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2019.01.008","article-title":"T-type calcium channels: From molecule to therapeutic opportunities","volume":"108","author":"Weiss","year":"2019","journal-title":"Int. J. BioChem. Cell Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"636103","DOI":"10.3389\/fnsyn.2021.636103","article-title":"Voltage-Gated Ca(2+) Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson\u2019s Disease?","volume":"13","author":"Ortner","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00424-010-0800-x","article-title":"Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels","volume":"460","author":"Striessnig","year":"2010","journal-title":"Pflugers Arch."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/mp.2017.9","article-title":"Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens","volume":"22","author":"Hao","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Ye, Q., Zhang, Z., Zhang, W., Ding, Y., Zhao, F., Zhang, J., and Song, Y. (2020). Investigation of the Selectivity of L-Type Voltage-Gated Calcium Channels 1.3 for Pyrimidine-2,4,6-Triones Derivatives Based on Molecular Dynamics Simulation. Molecules, 25.","DOI":"10.3390\/molecules25225440"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncomms2149","article-title":"CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson\u2019s disease","volume":"3","author":"Kang","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/acschembio.0c00577","article-title":"A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels","volume":"15","author":"Cooper","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1038\/ncomms5481","article-title":"Modest CaV1.342-selective inhibition by compound 8 is beta-subunit dependent","volume":"5","author":"Huang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1038\/ncomms4897","article-title":"Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators","volume":"5","author":"Ortner","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/mp.2015.84","article-title":"L-type Ca(2)(+) channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory","volume":"21","author":"Degoulet","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/chan.19805","article-title":"Chronic pregabalin inhibits synaptic transmission between rat dorsal root ganglion and dorsal horn neurons in culture","volume":"6","author":"Hendrich","year":"2012","journal-title":"Channels"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1533-2500.2009.00303.x","article-title":"Intrathecal ziconotide for neuropathic pain: A review","volume":"9","author":"Rauck","year":"2009","journal-title":"Pain Pract."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J. Pain Symptom Manag."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmcl.2009.09.008","article-title":"Scaffold-based design and synthesis of potent N-type calcium channel blockers","volume":"19","author":"Zamponi","year":"2009","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.111.075226","article-title":"Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels","volume":"81","author":"Swensen","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/cbdv.200590087","article-title":"Compositional diversity of terpenoids in the Himalayan Valeriana genera","volume":"2","author":"Mathela","year":"2005","journal-title":"Chem. Biodivers"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"45878","DOI":"10.1039\/C7RA07327E","article-title":"Ca(v)2.2 and Ca(v)3.1 calcium channel inhibitors from Valeriana jatamansi Jones","volume":"7","author":"Jiang","year":"2017","journal-title":"Rsc Adv."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.bmcl.2012.04.075","article-title":"A novel series of pyrazolylpiperidine N-type calcium channel blockers","volume":"22","author":"Subasinghe","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1021\/jm301056k","article-title":"Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain","volume":"55","author":"Shao","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"E10566","DOI":"10.1073\/pnas.1813157115","article-title":"Small-molecule CaValpha1CaVbeta antagonist suppresses neuronal voltage-gated calcium-channel trafficking","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.str.2007.11.010","article-title":"Alanine-scanning mutagenesis defines a conserved energetic hotspot in the CaValpha1 AID-CaVbeta interaction site that is critical for channel modulation","volume":"16","author":"Duderstadt","year":"2008","journal-title":"Structure"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1073\/pnas.1715997115","article-title":"STAC proteins associate to the IQ domain of CaV1.2 and inhibit calcium-dependent inactivation","volume":"115","author":"Campiglio","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: New advances","volume":"385","author":"Moshe","year":"2015","journal-title":"Lancet"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.59.9_suppl_5.S21","article-title":"Epilepsy after brain insult: Targeting epileptogenesis","volume":"59","author":"Herman","year":"2002","journal-title":"Neurology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.neuro.26.010302.081210","article-title":"The biology of epilepsy genes","volume":"26","author":"Noebels","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nurt.2007.01.009","article-title":"Channelopathies in idiopathic epilepsy","volume":"4","author":"Heron","year":"2007","journal-title":"Neurotherapeutics"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1152\/physrev.00002.2006","article-title":"Voltage-gated calcium channels and idiopathic generalized epilepsies","volume":"86","author":"Khosravani","year":"2006","journal-title":"Physiol. Rev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"107898","DOI":"10.1016\/j.neuropharm.2019.107898","article-title":"Seizure prediction and intervention","volume":"172","author":"Meisel","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1474-4422(11)70047-3","article-title":"The pharmacological treatment of epilepsy in adults","volume":"10","author":"Perucca","year":"2011","journal-title":"Lancet. Neurol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma","volume":"52","author":"Loscher","year":"2011","journal-title":"Epilepsia"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1474-4422(14)70156-5","article-title":"Epilepsy surgery in children and adults","volume":"13","author":"Ryvlin","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.2147\/NDT.S84852","article-title":"Managing drug-resistant epilepsy: Challenges and solutions","volume":"12","author":"Dalic","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_185","first-page":"49","article-title":"Block of T -Type Ca(2+) Channels Is an Important Action of Succinimide Antiabsence Drugs","volume":"2","author":"Huguenard","year":"2002","journal-title":"Epilepsy Curr."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1535-7597.2002.00024.x","article-title":"Block of Thalamic T-Type Ca(2+) Channels by Ethosuximide Is Not the Whole Story","volume":"2","author":"Crunelli","year":"2002","journal-title":"Epilepsy Curr."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-3458.2007.00009.x","article-title":"Ethosuximide: From bench to bedside","volume":"13","author":"Goren","year":"2007","journal-title":"CNS Drug Rev."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1254\/jphs.FP0050691","article-title":"The effects of ethosuximide on amino acids in genetic absence epilepsy rat model","volume":"100","author":"Terzioglu","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eplepsyres.2011.01.003","article-title":"Spontaneous epileptiform discharges in a mouse model of Alzheimer\u2019s disease are suppressed by antiepileptic drugs that block sodium channels","volume":"94","author":"Ziyatdinova","year":"2011","journal-title":"Epilepsy Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2008.11.010","article-title":"Zonisamide block of cloned human T-type voltage-gated calcium channels","volume":"83","author":"Matar","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1254\/jphs.08032FP","article-title":"Zonisamide suppresses pain symptoms of formalin-induced inflammatory and streptozotocin-induced diabetic neuropathy","volume":"107","author":"Tanabe","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"121ra19","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2015.02.017","article-title":"Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice","volume":"28","author":"Beiske","year":"2015","journal-title":"Seizure"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1523\/JNEUROSCI.5482-12.2013","article-title":"Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures","volume":"33","author":"Radzicki","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2009.04.036","article-title":"Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes","volume":"613","author":"Furukawa","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neuroscience.2006.12.054","article-title":"Age and gender-dependent alternative splicing of P\/Q-type calcium channel EF-hand","volume":"145","author":"Chang","year":"2007","journal-title":"Neuroscience"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuron.2014.04.017","article-title":"Age-related homeostatic midchannel proteolysis of neuronal L-type voltage-gated Ca(2)(+) channels","volume":"82","author":"Michailidis","year":"2014","journal-title":"Neuron"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"eaaf9647","DOI":"10.1126\/scisignal.aaf9659","article-title":"Phosphorylation of Ser1928 mediates the enhanced activity of the L-type Ca2+ channel Cav1.2 by the beta2-adrenergic receptor in neurons","volume":"10","author":"Qian","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1073\/pnas.2236970100","article-title":"Increased phosphorylation of the neuronal L-type Ca(2+) channel Ca(v)1.2 during aging","volume":"100","author":"Davare","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1074\/jbc.M117.799585","article-title":"Molecular mimicking of C-terminal phosphorylation tunes the surface dynamics of CaV1.2 calcium channels in hippocampal neurons","volume":"293","author":"Folci","year":"2018","journal-title":"J. Biol. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/4\/1312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:20:14Z","timestamp":1760134814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/4\/1312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":201,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["molecules27041312"],"URL":"https:\/\/doi.org\/10.3390\/molecules27041312","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}